128 related articles for article (PubMed ID: 26177681)
1. Prenatal screening at 11-13+6 weeks in assisted reproductive technology singleton pregnancies and those conceived naturally.
Gong M; Shi H; Zhang YG; Ming L
J Obstet Gynaecol Res; 2015 Oct; 41(10):1514-9. PubMed ID: 26177681
[TBL] [Abstract][Full Text] [Related]
2. [Clinical features of abnormal chromosome karyotypes in twin pregnancies complicated with structural abnormalities].
Zhong SL; Fang Q; Chen BJ; Han ZY; Luo YM; Chen JS; Xie YJ
Zhonghua Fu Chan Ke Za Zhi; 2011 Sep; 46(9):649-54. PubMed ID: 22176987
[TBL] [Abstract][Full Text] [Related]
3. [Study on several ultrasound markers combined maternal serum biochemical markers to screen fetal chromosomal aneuploidy at 11 to 13(+)6 weeks of gestation].
Chen X; Chang Y; Cui HY; Ren CC; Yu BY
Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):815-8. PubMed ID: 24444556
[TBL] [Abstract][Full Text] [Related]
4. The effect of a 'vanishing twin' on biochemical and ultrasound first trimester screening markers for Down's syndrome in pregnancies conceived by assisted reproductive technology.
Gjerris AC; Loft A; Pinborg A; Christiansen M; Tabor A
Hum Reprod; 2009 Jan; 24(1):55-62. PubMed ID: 18835870
[TBL] [Abstract][Full Text] [Related]
5. First-trimester screening in pregnancies conceived by assisted reproductive technology: significance of gestational dating by oocyte retrieval or sonographic measurement of crown-rump length.
Gjerris AC; Loft A; Pinborg A; Tabor A; Christiansen M
Ultrasound Obstet Gynecol; 2008 Oct; 32(5):612-7. PubMed ID: 18816495
[TBL] [Abstract][Full Text] [Related]
6. [Ultrasound screening for Down syndrome and other chromosomal abnormalities by fetal nuchal translucency measurement between 11-14 weeks of gestation].
Dimitrova V; Markov D; Chernev T; Karag'ozova Zh; Mazneĭkova V; Andonova S; Vŭzharova R
Akush Ginekol (Sofiia); 2005; 44(1):32-7. PubMed ID: 15853009
[TBL] [Abstract][Full Text] [Related]
7. Multivariate analysis identifies the estradiol level at ovulation triggering as an independent predictor of the first trimester pregnancy-associated plasma protein-A level in IVF/ICSI pregnancies.
Giorgetti C; Vanden Meerschaut F; De Roo C; Saunier O; Quarello E; Hairion D; Penaranda G; Chabert-Orsini V; De Sutter P
Hum Reprod; 2013 Oct; 28(10):2636-42. PubMed ID: 23887070
[TBL] [Abstract][Full Text] [Related]
8. Pregnancies conceived using assisted reproductive technologies (ART) have low levels of pregnancy-associated plasma protein-A (PAPP-A) leading to a high rate of false-positive results in first trimester screening for Down syndrome.
Amor DJ; Xu JX; Halliday JL; Francis I; Healy DL; Breheny S; Baker HW; Jaques AM
Hum Reprod; 2009 Jun; 24(6):1330-8. PubMed ID: 19246467
[TBL] [Abstract][Full Text] [Related]
9. Umbilical cord diameter at 11-14 weeks of gestation: relationship to nuchal translucency, ductus venous blood flow and chromosomal defects.
Axt-Fliedner R; Schwarze A; Kreiselmaier P; Krapp M; Smrcek J; Diedrich K
Fetal Diagn Ther; 2006; 21(4):390-5. PubMed ID: 16757918
[TBL] [Abstract][Full Text] [Related]
10. Does assisted reproductive technology itself or polycystic ovary syndrome as a cause of infertility have any effect on first trimester serum screening results?
Köşüş A; Köşüş N; Duran M; Turhan NO
J Reprod Med; 2012; 57(3-4):129-35. PubMed ID: 22523872
[TBL] [Abstract][Full Text] [Related]
11. Screening for trisomy 21 in twins using first trimester ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years experience.
Spencer K; Nicolaides KH
BJOG; 2003 Mar; 110(3):276-80. PubMed ID: 12628267
[TBL] [Abstract][Full Text] [Related]
12. Detection of triploidy at 11-14 weeks' gestation: a cohort study of 198 000 pregnant women.
Engelbrechtsen L; Brøndum-Nielsen K; Ekelund C; Tabor A; Skibsted L;
Ultrasound Obstet Gynecol; 2013 Nov; 42(5):530-5. PubMed ID: 23494847
[TBL] [Abstract][Full Text] [Related]
13. First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of impending fetal death.
Spencer K; Cowans NJ; Avgidou K; Nicolaides KH
Ultrasound Obstet Gynecol; 2006 Oct; 28(5):637-43. PubMed ID: 16952214
[TBL] [Abstract][Full Text] [Related]
14. Comparison of nuchal translucency measurement and mid-gestation serum screening in assisted reproduction versus naturally conceived singleton pregnancies.
Maymon R; Dreazen E; Rozinsky S; Bukovsky I; Weinraub Z; Herman A
Prenat Diagn; 1999 Nov; 19(11):1007-11. PubMed ID: 10589049
[TBL] [Abstract][Full Text] [Related]
15. Fetal nuchal translucency screening in 12495 pregnancies in Sardinia.
Zoppi MA; Ibba RM; Floris M; Monni G
Ultrasound Obstet Gynecol; 2001 Dec; 18(6):649-51. PubMed ID: 11844208
[TBL] [Abstract][Full Text] [Related]
16. Maternal serum biochemistry at 11-13(+6) weeks in relation to the presence or absence of the fetal nasal bone on ultrasonography in chromosomally abnormal fetuses: an updated analysis of integrated ultrasound and biochemical screening.
Cicero S; Spencer K; Avgidou K; Faiola S; Nicolaides KH
Prenat Diagn; 2005 Nov; 25(11):977-83. PubMed ID: 16245371
[TBL] [Abstract][Full Text] [Related]
17. [Value of nuchal translucency thickening in the fetal chromosome abnormality screening].
Sun LJ; Wang X; Wu QQ; Ruan Y; Yao L
Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):819-23. PubMed ID: 24444557
[TBL] [Abstract][Full Text] [Related]
18. A new approach to calculating the risk of chromosomal abnormalities with first-trimester screening data.
Merz E; Thode C; Alkier A; Eiben B; Hackelöer BJ; Hansmann M; Huesgen G; Kozlowski P; Pruggmaier M; Wellek S
Ultraschall Med; 2008 Dec; 29(6):639-45. PubMed ID: 19085755
[TBL] [Abstract][Full Text] [Related]
19. Nuchal translucency in twins according to mode of assisted conception and chorionicity.
Maymon R; Cuckle H; Svirsky R; Sheena L; Melcer Y; Rozen H; Ben-Ami I
Ultrasound Obstet Gynecol; 2014 Jul; 44(1):38-43. PubMed ID: 24339187
[TBL] [Abstract][Full Text] [Related]
20. The role of ductus venosus Doppler flow in the diagnosis of chromosomal abnormalities during the first trimester of pregnancy.
Florjański J; Fuchs T; Zimmer M; Homola W; Pomorski M; Blok D
Adv Clin Exp Med; 2013; 22(3):395-401. PubMed ID: 23828681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
